1997
DOI: 10.1002/(sici)1096-9896(199704)181:4<362::aid-path764>3.0.co;2-y
|View full text |Cite
|
Sign up to set email alerts
|

bcl-2 EXPRESSION IN PLEURAL AND EXTRAPLEURAL SOLITARY FIBROUS TUMOURS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
46
2

Year Published

1997
1997
2012
2012

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 164 publications
(53 citation statements)
references
References 29 publications
5
46
2
Order By: Relevance
“…A recent study has investigated CDK6 expression in both normal and (d) and (e) show increased staining for CDK6 compared to the CD19 negative populations. In (f) and (g) there is no comparable increase in CDK6 expression neoplastic lymphoid tissues using immunocytochemistry and¯ow cytometry (Chilosi et al, 1998). CDK6 was strongly expressed in both normal cortical thymocytes and T cell acute lymphoblastic leukemia or lymphoblastic lymphoma.…”
Section: Discussionmentioning
confidence: 93%
“…A recent study has investigated CDK6 expression in both normal and (d) and (e) show increased staining for CDK6 compared to the CD19 negative populations. In (f) and (g) there is no comparable increase in CDK6 expression neoplastic lymphoid tissues using immunocytochemistry and¯ow cytometry (Chilosi et al, 1998). CDK6 was strongly expressed in both normal cortical thymocytes and T cell acute lymphoblastic leukemia or lymphoblastic lymphoma.…”
Section: Discussionmentioning
confidence: 93%
“…47 Another marker that can be useful in this differential diagnosis is bcl-2, which has been reported to be expressed in 79 to 100% of synovial sarcomas, but in only 0 to 10% of mesotheliomas. [48][49][50][51] It should be mentioned, however, that TLE1, a marker that has an important role in the Wnt pathway and that has been shown to be a highly sensitive and specific immunohistochemical marker for synovial sarcoma, 52 was found in a recent study to be variably expressed in about 70% of mesotheliomas regardless of their histomorphologic subtype, thus demonstrating that immunostaining for this marker has little or no value in discriminating between synovial sarcomas and mesotheliomas. 53 Additionally, the demonstration of the distinctive t(x;18)(p11;q11) translocation that is reportedly present in nearly all synovial sarcomas can help to establish the correct diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…Mitotic activity varies from 0 to 50 per 10 hpf, and some cases have necrosis or hemorrhage. Immunohistochemically, strong and diffuse CD34 and bcl-2 expression is a feature of this tumor type [2,53,54]. Indeed, a CD34-negative tumor in an extrapleural location should probably not be diagnosed as solitary fibrous tumor unless other evidence is compelling [44].…”
Section: Solitary Fibrous Tumormentioning
confidence: 98%